RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies
NCT00508807
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Lymphoid Malignancies
Solid Tumors
Interventions
DRUG:
RTA 402
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]